AMG 176 is an MCL-1 inhibitor (myeloid cell leukemia-1) that can prevent cancer cells from creating proteins to protect itself, and can cause cell death.
| SparkCures ID | 263 |
|---|---|
| Developed By | Amgen |
| Generic Name | AMG 176 |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.